Terms: = Breast cancer AND CDKN2A, CDK4I, 1029, ENSG00000147889, P42771, p14, CMM2, ARF, TP16, p16, MTS1, p19, p16INK4a, INK4a, CDKN2, p16INK4, p14ARF, MLM, INK4 AND Staging
10 results:
1. Malignant pleural mesothelioma: recent developments.
Sinn K; Mosleh B; Hoda MA
Curr Opin Oncol; 2021 Jan; 33(1):80-86. PubMed ID: 33186182
[TBL] [Abstract] [Full Text] [Related]
2. The effect of treatment on patient-reported distress after breast cancer diagnosis.
Fayanju OM; Yenokyan K; Ren Y; Goldstein BA; Stashko I; Power S; Thornton MJ; Marcom PK; Hwang ES
Cancer; 2019 Sep; 125(17):3040-3049. PubMed ID: 31120575
[TBL] [Abstract] [Full Text] [Related]
3. Differential expression of senescence tumour markers and its implications on survival outcomes of breast cancer patients.
Pare R; Soon PS; Shah A; Lee CS
PLoS One; 2019; 14(4):e0214604. PubMed ID: 30998679
[TBL] [Abstract] [Full Text] [Related]
4. Correlations of breast cancer FHIT gene with the incidence and prognosis of breast cancer.
Fu Y; Shan X; Song W; Xu K; Jiao C; Zhang Q
J BUON; 2019; 24(1):40-47. PubMed ID: 30941950
[TBL] [Abstract] [Full Text] [Related]
5. The expression profile of p14, p53 and p21 in tumour cells is associated with disease-specific survival and the outcome of postoperative chemotherapy treatment in muscle-invasive bladder cancer.
Aljabery F; Shabo I; Gimm O; Jahnson S; Olsson H
Urol Oncol; 2018 Dec; 36(12):530.e7-530.e18. PubMed ID: 30539751
[TBL] [Abstract] [Full Text] [Related]
6. Expression of p16 and SATB1 in Invasive Ductal breast cancer - A Preliminary Study.
Kobierzycki C; Grzegrzolka J; Glatzel-Plucinska N; Piotrowska A; Wojnar A; Smolarz B; Romanowicz H; Dziegiel P
In Vivo; 2018; 32(4):731-736. PubMed ID: 29936452
[TBL] [Abstract] [Full Text] [Related]
7. Immunohistochemical detection and clinicopathological significance of JARID1B/KDM5B and p16 expression in invasive ductal carcinoma of the breast.
Zhao LH; Liu HG
Genet Mol Res; 2015 May; 14(2):5417-26. PubMed ID: 26125737
[TBL] [Abstract] [Full Text] [Related]
8. Lymph node melanocytic nevi: pathogenesis and differential diagnoses, with special reference to p16 reactivity.
Piana S; Tagliavini E; Ragazzi M; Zanelli M; Zalaudek I; Ciarrocchi A; Valli R
Pathol Res Pract; 2015 May; 211(5):381-8. PubMed ID: 25661066
[TBL] [Abstract] [Full Text] [Related]
9. Genomic and phenotypic analysis of BRCA2 mutated breast cancers reveals co-occurring changes linked to progression.
Stefansson OA; Jonasson JG; Olafsdottir K; Bjarnason H; Th Johannsson O; Bodvarsdottir SK; Valgeirsdottir S; Eyfjord JE
Breast Cancer Res; 2011 Sep; 13(5):R95. PubMed ID: 21958427
[TBL] [Abstract] [Full Text] [Related]
10. Methylated APC and GSTP1 genes in serum DNA correlate with the presence of circulating blood tumor cells and are associated with a more aggressive and advanced breast cancer disease.
Matuschek C; Bölke E; Lammering G; Gerber PA; Peiper M; Budach W; Taskin H; Prisack HB; Schieren G; Orth K; Bojar H
Eur J Med Res; 2010; 15(7):277-86. PubMed ID: 20696638
[TBL] [Abstract] [Full Text] [Related]
